Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer

Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer

We report the case of a 54-year-old man who was treated with nivolumab for recurrent squamous cell lung cancer. After 7 cycles of nivolumab treatment, the patient presented to our hospital with right eye vision loss. Gadolinium-enhanced magnetic resonance imaging of the brain showed enhancement arou...

Full description

Bibliographic Details
Main Authors: Kenji Takada, Keiichi Fujiwara, Eri Ando, Kiriko Onishi, Tadahiro Kuribayashi, Sho Mitsumune, Yuki Takigawa, Hiroaki Matsuura, Hiromi Watanabe, Kenichiro Kudo, Akiko Sato, Ken Sato, Takuo Shibayama
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Case Reports in Oncology
Subjects:
optic perineuritis
immune checkpoint inhibitor
immune-related adverse events
nivolumab
Online Access:https://www.karger.com/Article/FullText/516275

Internet

https://www.karger.com/Article/FullText/516275

Similar Items